OQS
GMED icon

Occudo Quantitative Strategies’s Globus Medical GMED Stock Holding History

Occudo Quantitative Strategies’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,011
Closed -$438K – 820
2025
Q4 		$438K Buy
+5,011
New +$380K 0.03% 423
2024
Q3 		– Sell
-8,267
Closed -$566K – 822
2024
Q2 		$566K Buy
8,267
+1,368
+20% +$81.7K 0.1% 275
2024
Q1 		$370K Buy
+6,899
New +$371K 0.06% 404
2023
Q4 		– Sell
-29,567
Closed -$1.47M – 941
2023
Q3 		$1.47M Buy
29,567
+24,371
+469% +$1.36M 0.19% 159
2023
Q2 		$309K Buy
+5,196
New +$296K 0.03% 732
2022
Q3 		– Sell
-16,666
Closed -$936K – 1278
2022
Q2 		$936K Buy
16,666
+7,260
+77% +$477K 0.08% 404
2022
Q1 		$694K Sell
9,406
-889
-9% -$61.8K 0.06% 519
2021
Q4 		$743K Sell
10,295
-1,616
-14% -$117K 0.07% 469
2021
Q3 		$913K Buy
11,911
+7,682
+182% +$617K 0.11% 321
2021
Q2 		$328K Buy
+4,229
New +$301K 0.05% 562

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Occudo Quantitative Strategies's GMED Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Globus Medical (GMED) in Q1 2026, closing a stake of 5,011 shares — an estimated $438K sold.

Occudo Quantitative Strategies first reported a position in GMED in Q2 2021 and held it in 10 quarters. The position peaked at $1.47M in Q3 2023. 607 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Globus Medical position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 5,011 Globus Medical shares in Q1 2026, an estimated $438K.
  • Occudo Quantitative Strategies first reported a position in Globus Medical in Q2 2021 and held it in 10 quarters.
  • Occudo Quantitative Strategies's Globus Medical position peaked at $1.47M in Q3 2023.
  • 607 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.